Combination therapywith radiolabeled anti-CD20 antibody in the treatment of B-cell lymphoma

Details for Australian Patent Application No. 2005261923 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Kalmus, Joachim; Kuhlmann, Jens; Krause, Werner

Agent Davies Collison Cave

Pub. Number AU-B-2005261923

PCT Pub. Number WO2006/005477

Priority 60/586,414 09.07.04 US

Filing date 7 July 2005

Wipo publication date 19 January 2006

Acceptance publication date 18 November 2010

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/005477 Priority application(s): WO2006/005477

18 November 2010 Application Accepted

  Published as AU-B-2005261923

17 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005261930-Novel tetrahydrocarbazole derivatives with improved biological action and improved solubility as ligands for Gprotein coupled receptors (GPCRs)

2005261908-Defibrillator with cardiac blood flow determination